OMB Program Assessment Tool Benefits Medical Device Review Reduction
This article was originally published in The Gray Sheet
Executive Summary
FDA's revised target for medical device review times would yield a nearly 10% reduction in total FDA days for half the premarket applications approved between fiscal 2005 and 2007